Segment Reporting

9 Months Ended

Sep. 30, 2014

Segment Reporting

13. Segment Reporting

The Company views its operations, makes decisions regarding how to allocate resources and manages its business as one operating segment. As a result, the financial information disclosed herein represents all of the material financial information related to the Company’s principal operating segment.

The following table represents the Company’s total revenue by geographic area (based on the location of the customer):

	Three months ended September 30,						Nine months ended September 30,
	2014			2013			2014			2013
Sweden		30	%		31	%		40	%		35	%
United States		38	%		56	%		34	%		51	%
United Kingdom		23	%		9	%		22	%		11	%
Other		9	%		4	%		4	%		3	%
Total		100	%		100	%		100	%		100	%

Revenue from significant customers as a percentage of the Company’s total revenue is as follows:

	Three months ended September 30,						Nine months ended September 30,
	2014			2013			2014			2013
Orencia® Royalties from Bristol		—			26	%		—			25	%
Bioprocessing Customer A		30	%		28	%		39	%		35	%
Bioprocessing Customer B		23	%		10	%		22	%		12	%
Bioprocessing Customer C		20	%		20	%		16	%		15	%

Significant accounts receivable balances as a percentage of the Company’s total trade accounts receivable and royalties and other receivables balances are as follows:

	September 30, 2014			December 31, 2013
Orencia® Royalties from Bristol		—			37	%
Bioprocessing Customer A		30	%		20	%
Bioprocessing Customer B		17	%		8	%
Bioprocessing Customer C		—			15	%
Tenant improvement allowance due from landlord		—			15	%
Pfizer		—			1	%